always online......
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOS ANGELES, CA, Mar 18, 2016 (Marketwired via COMTEX) -- Cannabis Science, Inc. (otc pink:CBIS), a U.S. company specializing in the development of cannabis-based medicines announces that it is expanding its California clinical drug development operations to work with its partner IGXBio, Inc. in developing effective therapeutics using IGXBio's Immuonotherapy (GenePro(R), also referred to as ?4SHIVKU2) FDA Investigational New Drug (IND). Number 015982.
GenePro(R) is an investigational DNA immunotherapy sponsored by IGXBio and would be considered a biologic. The Cannabis Science partnership is working to identify and develop agonist cannabinoids and IGXBio's GenePro(R).
GenePro(R) is a deoxyribonucleic acid (DNA) plasmid vaccine expressing simian immunodeficiency virus (SIV) and human immunodeficiency virus (HIV) proteins, which is administered by electroporation (EP). This FDA IND supports a biologic and device combination product.
HIV uses our immune system to infect healthy immunogenic cells and increase the opportunity of these cells to spread. HIV-1 proteins (gp120, Tat -- the transactivator of transcription, Vpr, and Nef) are released from infected cells throughout the course of infection and create an ongoing HIV disease burden in a number of tissues, including the central nervous system (CNS), resulting in toxicity and damage, regardless of ART.
A substantial number of individuals with HIV disease suffer brain impairment such as HIV-1 associated cognitive impairment (HAND) and dementia. Many standard anti-retroviral drugs cannot cross the blood-brain barrier (BBB) and therefore they have no effect on HIV infection in the brain.
"To further cement our foothold in the substantial pharmaceutical drug development industry, we expect our IGXBio, GenePro(R) drug development program to be a major pharmaceutical success. Program specific details are underway and we will update progress and results as they come in," stated Dr. Allen Herman, Cannabis Science Inc., Chief Medical Officer (CMO).
About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
Forward-Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward-looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward- looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company are detailed from time to time in the company's reports filed with the Securities and Exchange Commission.
IGXBio
Mr. Jim Laufenberg
President and CEO
Direct: 1.888.744.9246
info@igxbio.com
Cannabis Science, Inc.
Allen A. Herman, M.B., Ch.B., Ph.D.
Chief Medical Officer, SAB & IGAB Member
allen.herman@cannabisscience.com
Direct: 1.240.274.8094
Cannabis Science, Inc.
Mr. Raymond C. Dabney
President & CEO, Co-Founder
raymond.dabney@cannabisscience.com
Direct: 1.310.650.3788
SOURCE: Cannabis Science, Inc.
(C) 2016 Marketwire L.P. All rights reserved.
Long Term Indicators Average: 100% Buy
http://www.barchart.com/opinions/stocks/MCIG
Medium Term Indicators Average: 100% Buy
http://www.barchart.com/opinions/stocks/MCIG
Weeeeeeeeeeeeeeeeeeeee......CBIS...............
(+181.77%) Since 12/10/15MCIG
http://www.barchart.com/quotes/stocks/MCIG
Overall Average: 96% Buy
http://www.barchart.com/opinions/stocks/MCIG
Medium Term Indicators Average: 100% Buy
http://www.barchart.com/opinions/stocks/MCIG
Long Term Indicators Average: 100% Buy
http://www.barchart.com/opinions/stocks/MCIG
mCigInc.to Enter Untapped Cannabis Home Grow MarketMar 17, 2016
OTC Disclosure & News Service
mCig Inc. to Enter Untapped Cannabis Home Grow Market
HENDERSON, NV--(Marketwired - Mar 17, 2016) - mCig's Grower Services Division "GSD" (OTCQB: MCIG) announced today it is entering into the Cannabis Home Grow Market with its own brand of conversion kits, starting with three pre-determined sizes; 4' x 4' x 8', 4' x 8' x 8', and 8' x 8' x 8'. Please visit http://mcig.org/personal-cultivators/ for more information on mCig products for personal cultivation.
"mCig is dedicated to offering customers the best solution for their home growing needs," says Jori Olson, VP of GSD Sales. "We're taking the exact SIP Paneling methods we use to construct highly regulated commercial cultivation centers, and applying it to personal cultivation. They are easy to store and can even be fashioned as furniture with the various looks we have developed. Combining this design with name brand mechanics, including LED options, makes us confident the concept will work and prove to be a great success in this space."
With an industry currently focused on commercial scale cultivation, the educational resources on home growing are limited. Although this area of cultivation is unregulated, mCig Inc. is confident it will reach a vast amount of home grow patients in all legalized states with their comprehensive product development and strategic market penetration.
Paul Rosenberg, mCig's CEO, stated, "We are preparing ourselves to capture a great deal of the Home Grow Market and provide consumers with a complete product and service guarantee. This completes a well rounded commitment to help growers of varying crop sizes, and will allow mCig to further gauge industry regulations and trends to continually improve its offerings accordingly."
About mCig, Inc.
Headquartered in Henderson, NV, mCig, Inc. (OTCQB: MCIG) is a leading provider of advanced technologies and solutions to the global cannabis industry. mCig manufactures and markets best-selling portable and home vaporizers, extraction related equipment, CBD Rich Hemp Oil-derived products, and related nutraceuticals based on natural compounds found in Cannabis and Hemp plants. The company owns the mCig and Vapolution brands, and has a 47% stake in VitaCig (VTCQ), makers of the VitaStik, a disposable vitamin vaporizer. The company believes that a well-regulated marijuana industry is emerging as more states follow the lead of Alaska, Colorado, Oregon, and Washington in legalizing marijuana. A similar trend is developing within the CBD and Hemp industries following overwhelming consumer demand.
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.
mCig, Inc.
Paul Rosenberg
CEO
paul@mcig.org
mCig Rolls Out Its First Cannabis Brand Mar 14, 2016
OTC Disclosure & News Service
mCig Rolls Out Its First Cannabis Brand
HENDERSON, NV--(Marketwired - Mar 14, 2016) - mCig, Inc. (the "Company") (OTCQB: MCIG) is pleased to announce a new brand of exceptional quality cannabis products. Rollie's is a wholly owned subsidiary of mCig Inc., giving it the missing piece in its brand-offering arsenal. mCig has always wanted to roll out a THC brand for the medicinal and recreational markets and fully commit to the Cannabis sector. Rollie's marijuana cigarettes are based on pre-rolled tubes manufactured by "Blanks" made out of the finest rice paper that are extra thin, slow burning, and do not change the taste of the flower.
"We are proud to offer patients a variety of marijuana cigarettes that will satisfy the needs and demands of a wide range of smokers regardless of taste and size preferences," said Alex Levitsky, CEO of Rollie's LLC. "The regular size marijuana cigarette is about the size of a traditional tobacco cigarette and the Mini is the best option for occasional smokers, and people who simply prefer smoking a smaller quantity. The elegant metal box contains 6 perfectly crafted mini marijuana cigarettes."
Rollie's products will only be available to qualified patients through permitted medical cannabis dispensaries. The company has launched a Rollie's branding page on the corporate website, http://mcig.org/rollies/. Through the website, patients and brand enthusiasts will be able to learn more about the products offered by mCig, find local retailers, as well as purchase Rollie's branded gear.
"We have always wanted our own THC brand, and now with the successful push to work closely with cultivators and dispensaries in Nevada, we see the chance to start our first THC brand in this key state," says Paul Rosenberg. "We will have a direct sales approach and we will be working with one of our cultivation clients to keep overhead and costs very low. This is the right time to add the newest brand to our product lines and to look forward to fast growth within the developing Nevada market."
About mCig, Inc.
Headquartered in Henderson, NV, mCig, Inc. (OTCQB: MCIG) is a leading provider of advanced technologies and solutions to the global cannabis industry. mCig manufactures and markets best-selling portable and home vaporizers, extraction related equipment, CBD Rich Hemp Oil-derived products, and related nutraceuticals based on natural compounds found in Cannabis and Hemp plants. The company owns the mCig and Vapolution brands, and has a 47% stake in VitaCig (VTCQ), makers of the VitaStik, a disposable vitamin vaporizer. The company believes that a well-regulated marijuana industry is emerging as more states follow the lead of Alaska, Colorado, Oregon, and Washington in legalizing marijuana. A similar trend is developing within the CBD and Hemp industries following overwhelming consumer demand.
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.
mCig, Inc.
Paul Rosenberg
CEO
paul@mcig.org
Copyright © 2016 Marketwired. All Rights Reserved
Mar 10,2016 OTC Disclosure & News Service
mCig Announces Agreement With Green Leaf Farms to Construct Large Scale Cultivation and Production Facility in North Las Vegas
HENDERSON, NV--(Marketwired - Mar 10, 2016) - mCig's Grower Services Division "GSD" (OTC PINK: MCIG) and Players Network (OTC PINK: PNTV) announces today that it has entered into an agreement to develop for Players Network subsidiary Green Leaf Farms, a large scale 26,000 sq. ft. cultivation and production facility in North Las Vegas, Nevada. Green Leaf has made a deposit for the design and build out of a phased out plan designed to grow with the Nevada Medical Marijuana market.
"mCig is excited about our recent successes on the West Coast. The Green Leaf Farms project will be our third fully customized facility using mCig's proprietary SIP panel construction for large scale growers," says Jori Olson VP of GSD Sales. "Recent states to permit medical use have new cultivators looking for knowledgeable construction personnel to perfectly understand their needs, and we are filling that space. The mCig construction team's knowledge and experience provides for fast and more economical construction compared to local contractors trying to break into the Cannabis space. mCig has invested heavily in servicing growers with construction expertise."
mCig's CEO Paul Rosenberg added, "We are very excited to work on this project with the Green Leaf team, they have an incredible vision and want to set the bar high by pushing the limits in the development of a cultivation facility."
"The mCig system will provide Green Leaf Farms facility super high-tech clean cultivation rooms with a modern look that houses perfect grow environments at a cost much less than traditional construction and quicker speed to market. This backdrop will make great content for our television series and it will become the facility to watch in Las Vegas," said Mark Bradley CEO of Green Leaf Farms and Players Network.
Bradley added, "We are also very excited to announce that the entire process of building the Green Leaf Farms facility by mCig is being filmed by our subsidiary, WeedTV, to be featured as part of a documentary series."
About mCig, Inc.:
Headquartered in Henderson, NV, mCig, Inc. (OTCQB: MCIG) is a leading provider of advanced technologies and solutions to the global cannabis industry. mCig manufactures and markets best-selling portable and home vaporizers, extraction related equipment, CBD Rich Hemp Oil-derived products, and related nutraceuticals based on natural compounds found in Cannabis and Hemp plants. The company owns the mCig and Vapolution brands, and has a 47% stake in VitaCig (VTCQ), makers of the VitaStik, a disposable vitamin vaporizer. The company believes that a well-regulated marijuana industry is emerging as more states follow the lead of Alaska, Colorado, Oregon, and Washington in legalizing marijuana. A similar trend is developing within the CBD and Hemp industries following overwhelming consumer demand.
About Player's Network:
Player's Network is a diversified company with holdings in both Media and Medical Marijuana. The Company uses its proprietary Enterprise Web Platform to develop Branded Digital Lifestyle Television Networks for itself and its partners in a wide range of lifestyle categories. Player's Network's current original channels, "Player's Network", "Vegas on Demand", "Real Vegas TV", focus on the Las Vegas and Gaming Lifestyles. These channels are distributed over PNTV's owned and operated VOD Channels over its Broadband Network and Mobile Platforms. The Medical Marijuana assets are primarily through the Company's 80% ownership in Greenleaf Farms Holdings, and PNTV's newest channel, "WeedTV.com," which focuses on the rapidly expanding cannabis community. For more information please visit www.playersnetwork.com.
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.
Paul Rosenberg
CEO
paul@mcig.org
Copyright © 2016 Marketwired. All Rights Reserved
Long Term Indicators Average: 100% Buy
http://www.barchart.com/opinions/stocks/MCIG
Yep.....Mcig....
3 x 100 % WOW http://www.barchart.com/opinions/stocks/MCIG
GLTA....MCIG....
Real-Time Best Bid&Ask 0.048/0.052
http://www.otcmarkets.com/stock/MCIG/quote
Mar 15,2016 VitaCig, Inc. Appoints E-cig Industry Expert Glenn Kassel, New CEO
BEVERLY HILLS, CA--(Marketwired - March 15, 2016) - VitaCig, Inc. (OTC PINK: VTCQ), a technology company that is harnessing mobile vaporization technology for multiple delivery applications, as well as a leader in the development, marketing, and sale of ultra-pure CBD tinctures, Edibles, and E-Liquids, announces today that its board has unanimously chosen Glenn Kassel as the organization's next Chief Executive Officer. Glenn Kassel will replace current VitaCig founder and CEO, Paul Rosenberg. Paul Rosenberg will remain with VitaCig Inc. as a member of the board of directors. Kassel’s appointment as CEO marks a strategic move by VitaCig Inc. to tap a visionary leader with a wealth of business and industry knowledge to take the company to the next level.
Outgoing CEO Paul Rosenberg comments, "As VitaCig opens this new chapter, the VitaCig Board and I are confident that Mr. Kassel is the right person to lead the company forward. Mr. Kassel’s industry specific knowledge, contacts, sales experience, and complimentary management and leadership style will greatly benefit the entire organization. I pass the baton with much confidence that I have laid a great foundation for Glenn to build upon. VitaCig has never been so well positioned to succeed and drive revenues, as it is today. Lastly, I have no doubt Mr. Kassel will continue to prioritize shareholders, build company value, and avoid toxic financing and highly dilutive transactions just as I have. We are thrilled that he has joined the VitaCig team and know that our shareholders will be thrilled as well.”
Glenn is an entrepreneur with a strong business mind, providing time and leadership with several large successful Corporations (including Mobil Oil, McDonald’s Worldwide, Disney, Wendy’s, and Denny’s). He has a track record of scaling revenues and increasing profits, all while building solid sales and operational teams. Glenn was an pioneer in the vaping industry, long before ‘Vape’ became Oxford Dictionary’s Word of the Year 2014. In 2008, Glenn became President and Co-Founder of Freedom Smokeless, Inc., an importer of components and OEM manufacturer for the electronic cigarette industry. Originally producing their own Freedom Smokeless brand and private labeling for others, Freedom changed course in 2011 and focused mainly on the manufacturing side of the industry. Freedom created the first automated e-liquid filling machines in the U.S. Using only U.S. made e-liquid and U.S. packaging services, he proudly brought jobs back here to the U.S.
Product Development:
•Has worked with major China e-cig operations, meeting not only with the owners of the manufacturing companies, but with some key component suppliers (batteries, cotton, tubes, etc.) as well.
•Assisted with development of the first soft tip disposable with a mouth tip that bonded to the PC tube (won’t pop off).
•Helped design a soft tip disposable designed to properly vape CBD eliquid.
•Assisted with design of tanks and disposables designed for THC oils, able to properly wick/vaporize even thick liquids (70% THC) without a burnt taste and no leaking.
CBD:
•Worked with several suppliers of CBD liquids.
•Working with a lab that is creating a full-line of CBD products from liquid to gum to breath strips.
Glenn is the longest tenured member on the Board of Directors of SFATA (Smoke-Free Alternatives Trade Association), which is the largest group (almost 1000 members) representing the vaping industry. He has been active in speaking at the FDA, as well as being active in State and Federal lobbying to educate legislators and regulatory organizations about vapor products.
Newly appointed CEO Glenn Kassel comments, “I am honored and excited to join VitaCig, Inc. as their Chief Executive Officer. I am humbled to be in a position to build and protect shareholder value. I look forward to helping the VitaCig team capitalize on numerous domestic and international opportunities that are available for their expanding product lines. Having extensive experience in the electronic cigarette industry since 2008, and deep understanding of the CBD sciences and Industry, I know that I can add value to the company when it comes to supply chain management, product development, product safety, and sales. I feel that VitaCig is uniquely positioned to capture a nice share of a still, growing and trending industry. I am also extremely excited about the prospects for VitaCig’s VitaCBD Division. CBD sciences, and the growing public awareness and reception for CBD in general, has explosive growth potential, in my opinion. I Iook forward to helping the company increase their market presence and profitability, and I am excited to build on the strong foundation that Paul has laid out as we turn a new chapter in the Company's young history. Shareholders have a lot to look forward to, thank you in advance for your support.”
About VitaCig, Inc.
VitaCig, Inc. (OTCPINK: VTCQ) is a technology company harnessing mobile vaporization technology for medical delivery applications. The company owns, manufactures, and distributes the VitaCig®, a nicotine-free device, as well as a leader in the development, marketing, and sale of ultra-pure CBD Oil tinctures, Edibles, and E-Liquids. The company's products are sold online at: www.mcig.org, www.vitacbd.com, www.vitacig.org, or through affiliate websites and select brick and mortar locations.
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.
Contact:
VitaCig, Inc.
Glenn Kassel
CEO
Glenn@vitacig.org
Short Term Indicators Average: 80% Buy
Overall Average: 96% Buy
Medium Term Indicators Average: 100% Buy
http://www.barchart.com/opinions/stocks/MCIG